Aptatek BioSciences

Aptatek BioSciences is developing game-changing home monitoring tools for chronic disease patients and medication management. The Aptatek system combines its proprietary aptamer assay approach with a handheld, smartphone-based test platform. The company has already received Breakthrough Device designation by the FDA, for its first product - a phenylketonuria (PKU) monitoring test.

Columbia BiomedX Cohort: 2012-2013

Key Focus Area(s): Diagnostics, Medical Devices